Research without borders: fostering innovative clinical research and implementation
暂无分享,去创建一个
[1] V. Feigin,et al. Global Burden of Stroke. , 2017, Circulation research.
[2] Adrian F Hernandez,et al. Strategies Used by Hospitals to Improve Speed of Tissue-Type Plasminogen Activator Treatment in Acute Ischemic Stroke , 2014, Stroke.
[3] P. Elliott,et al. A large-scale cluster randomized trial to determine the effects of community-based dietary sodium reduction--the China Rural Health Initiative Sodium Reduction Study. , 2013, American heart journal.
[4] Andrew E Moran,et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global Burden of Disease Study 2010 , 2013, The Lancet. Global health.
[5] David Erlinge,et al. Thrombus aspiration during ST-segment elevation myocardial infarction. , 2013, The New England journal of medicine.
[6] M. Wintermark,et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2013, Stroke.
[7] Eric E. Smith,et al. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. , 2012, JAMA.
[8] E. Peterson,et al. Effect of a multifaceted intervention on use of evidence-based therapies in patients with acute coronary syndromes in Brazil: the BRIDGE-ACS randomized trial. , 2012, JAMA.
[9] Eric E. Smith,et al. Improving Door-to-Needle Times in Acute Ischemic Stroke: The Design and Rationale for the American Heart Association/American Stroke Association's Target Stroke Initiative , 2011, Stroke.
[10] Liping Liu,et al. The China National Stroke Registry for Patients with Acute Cerebrovascular Events: Design, Rationale, and Baseline Patient Characteristics , 2011, International journal of stroke : official journal of the International Stroke Society.
[11] Adrian F Hernandez,et al. Timeliness of Tissue-Type Plasminogen Activator Therapy in Acute Ischemic Stroke: Patient Characteristics, Hospital Factors, and Outcomes Associated With Door-to-Needle Times Within 60 Minutes , 2011, Circulation.
[12] R. Sacco,et al. Translating Evidence Into Practice: A Decade of Efforts by the American Heart Association/American Stroke Association to Reduce Death and Disability Due to Stroke: A Presidential Advisory From the American Heart Association/American Stroke Association , 2010, Stroke.
[13] Eric E. Smith,et al. Characteristics, Performance Measures, and In-Hospital Outcomes of the First One Million Stroke and Transient Ischemic Attack Admissions in Get With The Guidelines-Stroke , 2010, Circulation. Cardiovascular quality and outcomes.
[14] S Claiborne Johnston,et al. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling , 2009, The Lancet Neurology.
[15] J. Mehler. Research Without Borders , 2008 .
[16] Elizabeth R DeLong,et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. , 2006, JAMA.
[17] C. Dolea,et al. World Health Organization , 1949, International Organization.
[18] Alan D. Lopez,et al. The Global Burden of Disease Study , 2003 .